MORINDA CITRIFOLIA L. AND HYLOCEREUS SPP: FROM TRADITIONAL USES TO MODERN APPLICATIONS
Main Article Content
Keywords
Morinda Citrifolia, Noni, Hylocereus, Dragon Fruit, Ethnobotany , Traditional Medicine, Modern Applications, Bioactive Compounds, Health Benefits , Pharmacological Activities, Side Effects.
Abstract
Since morinda citrifolia (Noni) possesses strong antioxidant properties and well-established health advantages, it has been used as an alternative and complementary medicine for a long time in many countries. As an antibacterial, anticancer, anthelminthic, analgesic, anti-inflammatory, and immunostimulant, it has historically been used to treat a wide range of illnesses. Moreover, studies have demonstrated its efficacy in treating menstruation pain and urinary tract infections, diabetes, gastritis, skin conditions, respiratory infections, fever, and arthritis. The dragon fruit, also known as pitaya, is an exotic tropical plant that provides several health benefits due to its high nutritional content and bioactive components, which include potent natural antioxidants. Dragon fruit, which originates in Central and South America, is prized for its nutritional content and traditional medical applications, such as easing digestion and boosting the body's immune system. The stems, blossoms, peels, and pulps of dragon fruit have extracts that have a range of biologically active medicinal properties against diseases like diabetes, obesity, hyperlipidaemia, and cancer, as well as pathogenic microbes like bacteria, fungi, and viruses. Additionally, dragon fruit extracts show possible prebiotic properties along with cardiovascular and hepatoprotective effects. Furthermore, this analysis supports the pharmacological underpinnings of Noni and Dragon fruit's numerous health advantages as well as their traditional and medical uses. Dragon fruit extracts, including those from the stems, blossoms, peels, and pulps, have a range of biologically active therapeutic benefits against diseases like diabetes, obesity, hyperlipidaemia, and cancer, as well as pathogenic microbes like bacteria, fungi, and viruses. Additionally, dragon fruit extracts show possible prebiotic properties along with cardiovascular and hepatoprotective effects. Furthermore, this analysis supports the pharmacological underpinnings of Noni and Dragon fruit's numerous health advantages as well as their traditional and medical uses.
Objective: The purpose of this review is to examine how Hylocereus and Morinda citrifolia have evolved from their historic uses to contemporary ones. This review of the literature examined the pharmacological activities, chemical composition, historical and cultural relevance, traditional medical use, nutritional qualities, therapeutic uses, and botanical description of Hylocereus and Morinda citrifolia. The intention is to offer a thorough grasp of their possible advantages and prospects in the fields of health and medicine going forward.
References
1. Wang, M. Y., West, B. J., Jensen, C. J., Nowicki, D., Su, C., Palu, A. K., & Anderson, G. (2002). Morinda citrifolia (Noni): a literature review and recent advances in Noni research. Acta Pharmacologica Sinica, 23(12), 1127-1141.
2. Nagalingam, S., Sasikumar, C. S., & Cherian, K. M. (2013). International Journal of Universal Pharmacy and Bio Sciences,2(6) ,(ISSN): 2319-8141
3. Dixon, A.R., McMillen, H., Etkin, N.L., 1999. Ferment this: the transformation of Noni, a traditional Polynesian medicine (Morinda citrifolia, Rubiaceae). Economic Botany ,53, 51–68.
4. McClatchey, W. (2002). From Polynesian healers to health food stores: changing perspectives of Morinda citrifolia (Rubiaceae). Integrative cancer therapies, 1(2), 110-120.
5. Jadhav, S. B., & Jadhav, N. Y. (2023). An eye catching and comprehensive review on dragon fruit (An exotic super fruit). Journal of Pharmacognosy and Phytochemistry, 12(6), 243-251.
6. Luu, T. T. H., Le, T. L., Huynh, N., & Quintela-Alonso, P. (2021). Dragon fruit: A review of health benefits and nutrients and its sustainable development under climate changes in Vietnam. Czech Journal of Food Sciences, 39(2), 71-94.
7. Vuanghao, L., & Laghari, M. H. (2017). Morinda citrifolia (Noni): A comprehensive review on its industrial uses, pharmacological activities, and clinical trials. Arabian Journal of Chemistry, 10, 691-707
8. Pawlus, A. D., & Kinghorn, A. D. (2007). Review of the ethnobotany, chemistry, biological activity and safety of the botanical dietary supplement Morinda citrifolia (noni). Journal of Pharmacy and pharmacology, 59(12), 1587-1609.
9. Mathivanan, N., Surendiran, G., Srinivasan, K., Sagadevan, E., & Malarvizhi, K. (2005). Review on the current scenario of Noni research: Taxonomy, distribution, chemistry, medicinal and therapeutic values of Morinda citrifolia. International Journal of Noni Research, 1(1), 1-16.
10. Inada, A. C., Figueiredo, P. S., Santos-Eichler, R. A. D., Freitas, K. D. C., Hiane, P. A., Castro, A. P. D., & Guimarães, R. D. C. A. (2017). Morinda citrifolia Linn.(Noni) and its potential in obesity-related metabolic dysfunction. Nutrients, 9(6), 540.
11. Ali, M., Kenganora, M., & Manjula, S. N. (2016). Health benefits of Morinda citrifolia (Noni): A review. Pharmacognosy Journal, 8(4).
12. Morton, J.F., 1992. The ocean-going Noni, or Indian mulberry (Morinda citrifolia, Rubiaceae) and some of its ‘‘colourful’’ relatives. Economic Botony ,46(3), 241–256
13. Elkins, R., 1998. Hawaiian Noni (Morinda citrifolia) Prize Herb of Hawaii and the South Pacific. Woodland Publishing, Utah.
14. Dixon, A. R., McMillen, H., & Etkin, N. L. (1999). Ferment this: the transformation of Noni, a traditional Polynesian medicine (Morinda citrifolia, Rubiaceae). Economic botany, 51-68.
15. Ross, I. A. (2001). Glycyrrhiza glabra. In Medicinal Plants of the World: Chemical Constituents, Traditional and Modern Medicinal Uses, Volume 2 (pp. 191-240). Totowa, NJ: Humana Press.
16. Cardon, D., 2003. Le Monde des Teintures Naturelles. Belin, Paris.
17. Chan-Blanco, Y., Vaillant, F., Perez, A. M., Reynes, M., Brillouet, J. M., & Brat, P. (2006). The noni fruit (Morinda citrifolia L.): A review of agricultural research, nutritional and therapeutic properties. Journal of food composition and analysis, 19(6-7), 645-654.
18. Krishnaiah, D., Nithyanandam, R., & Sarbatly, R. (2012). Phytochemical constituents and activities of Morinda citrifolia L. Phytochemicals-a global perspective of their role in nutrition and health, 127-150.
19. WANG, M. Y., & Su, C. (2001). Cancer preventive effect of Morinda citrifolia (Noni). Annals of the New York Academy of Sciences, 952(1), 161-168.
20. Dittmar, A. (1993). Morinda citrifolia L.-: Use in Indigenous Samoan Medicine. Journal of Herbs, Spices & Medicinal Plants, 1(3), 77–92.
21. Heinicke, R. M. (1985). The pharmacologically active ingredient of Noni. Bulletin of the national tropical Botanical garden, 15(1), 45-52
22. Mahanthesh, M. C., Manjappa, A. S., Shindhe, M. V., Jamkhandi, C. M., Jalapure, S. S., & Patil, S. S. (2013). Morinda citrifolia Linn; A medicinal plant with diverse phytochemicals and its medicinal relevance. World J. Pharm. Res, 3(1), 215-232.
23. Patil, P., Madkaikar, H., & Shah, N. (2022). Morinda citrifolia L.(Noni)-Its ethnobotanical knowledge, phytochemical studies, pharmacological aspects, and future prospects. Int. J. Nov. Res. Dev.(IJNRD), 7, 331-352.
24. Brown, A. C. (2012). Anticancer activity of Morinda citrifolia (Noni) fruit: a review. Phytotherapy Research, 26(10), 1427-1440
25. Chanthira Kumar, H., Lim, X. Y., Mohkiar, F. H., Suhaimi, S. N., Mohammad Shafie, N., & Chin Tan, T. Y. (2022). Efficacy and safety of Morinda citrifolia L.(noni) as a potential anticancer agent. Integrative cancer therapies, 21, 15347354221132848
26. Atkinson, N. (1956). Antibacterial substances from flowering plants. 3. Antibacterial activity of dried Australian Plants by rapid direct plate test, Australian Journal of Experimental Biology, Vol.34(1), pp. 17-26, ISSN 0004-945X
27. Locher, C. P., Burch, M. T., Mower, H. F., Berestecky, J., Davis, H., Van Poel, B., ... & Vlietinck, A. J. (1995). Anti-microbial activity and anti-complement activity of extracts obtained from selected Hawaiian medicinal plants. Journal of ethnopharmacology, 49(1), 23-32.
28. Saludes, J. P., Garson, M. J., Franzblau, S. G., & Aguinaldo, A. M. (2002). Antitubercular constituents from the hexane fraction of Morinda citrifolia Linn.(Rubiaceae). Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives, 16(7), 683-685.
29. Ancolio, C., Azas, N., Mahiou, V., Ollivier, E., Keita, A., Timon David, P., (2000 Feb 29). Anonymous Guinea pig antigenicity study. TAHITIAN NONI® . Product safety labs (Eurofins scientific, Inc) East Drunswick, New Jersey, USA
30. Hirazumi, A., Furusawa, E., Chou, S. C., & Hokama, Y. (1996, January). Immunomodulation contributes to the anticancer activity of morinda citrifolia (noni) fruit juice. In Proceedings of the Western Pharmacology Society (Vol. 39, pp. 7-9).
31. Hirazumi, A., Furusawa, E., Chou, S. C., & Hokama, Y. (1994, January). Anticancer activity of Morinda citrifolia (noni) on intraperitoneally implanted Lewis lung carcinoma in syngeneic mice. In Proceedings of the Western pharmacology society (Vol. 37, pp. 145-146).
32. Anekpankul, T., Goto, M., Sasaki, M., Pavasant, P., & Shotipruk, A. (2007). Extraction of anti-cancer damnacanthal from roots of Morinda citrifolia by subcritical water. Separation and Purification Technology, 55(3), 343-349.
33. Ali, M., Singh, P., Singh, L., Kumar, S., & Scholar, P. G. (2020). Phytochemical Constituents and Pharmacological Activities, Profile of Morinda Citrifolia: A Review. World Journal of Pharmaceutical Research, 9(14), 422.
34. Auerbach, B. J., Kiely, J. S., & Cornicelli, J. A. (1992). A spectrophotometric microtiter-based assay for the detection of hydroperoxy derivatives of linoleic acid. Analytical biochemistry, 201(2), 375-380.
35. Wang, M.Y., Su, C., Nowicki, D., Jensen, J. and Anderson, G. (2001). Morinda citrifolia and cancer prevention. J. Nutrition,131 (11S),3151S
36. Masuda, M., Murata, K., Fukuhama, A., Naruto, S., Fujita, T., Uwaya, A., ... & Matsuda, H. (2009). Inhibitory effects of constituents of Morinda citrifolia seeds on elastase and tyrosinase. Journal of Natural Medicines, 63, 267-273.
37. Jayaraman, S. K., Manoharan, M. S., & Illanchezian, S. (2008). Antibacterial, antifungal and tumor cell suppression potential of Morinda citrifolia fruit extracts. International Journal of Integrative Biology, 3(1), 44-49.
38. Dussossoy, E., Brat, P., Bony, E., Boudard, F., Poucheret, P., Mertz, C., Giaimis, J., & Michel, A. (2011). Characterization, anti-oxidative and anti-inflammatory effects of Costa Rican noni juice (Morinda citrifolia L.). Journal of ethnopharmacology, 133(1), 108–115.
39. Serafini, M. R., Santos, R. C., Guimarães, A. G., Dos Santos, J. P., da Conceicão Santos, A. D., Alves, I. A., Gelain, D. P., de Lima Nogueira, P. C., Quintans-Júnior, L. J., Bonjardim, L. R., & de Souza Araújo, A. A. (2011). Morinda citrifolia Linn leaf extract possesses antioxidant activities and reduces nociceptive behavior and leukocyte migration. Journal of medicinal food, 14(10), 1159–1166.
40. Nerurkar, P. V., Nishioka, A., Eck, P. O., Johns, L. M., Volper, E., & Nerurkar, V. R. (2012). Regulation of glucose metabolism via hepatic forkhead transcription factor 1 (FoxO1) by Morinda citrifolia (noni) in high-fat diet-induced obese mice. British Journal of Nutrition, 108(2), 218-228.
41. Nayak, B. S., Marshall, J. R., Isitor, G., & Adogwa, A. (2011). Hypoglycemic and hepatoprotective activity of fermented fruit juice of Morinda citrifolia (Noni) in diabetic rats. Evidence‐Based Complementary and Alternative Medicine, 2011(1), 875293.
42. Palu, A. K., Kim, A. H., West, B. J., Deng, S., Jensen, J., & White, L. (2008). The effects of Morinda citrifolia L.(noni) on the immune system: its molecular mechanisms of action. Journal of Ethnopharmacology, 115(3), 502-506.
43. Saraswathi, C. D., Prakash, W. S., & Kunal, P. W. (2012). Anti-arthritic activity of Morinda citrifolia L. fruit juice in Complete Freund's Adjuvant induced arthritic rats.
44. Rasal, V. P., Sinnathambi, A., Ashok, P., & Yeshmaina, S. (2008). Wound healing and antioxidant activities of Morinda citrifolia leaf extract in rats.
45. Kamata, M., Wu, R. P., An, D. S., Saxe, J. P., Damoiseaux, R., Phelps, M. E., ... & Chen, I. S. (2006). Cell-based chemical genetic screen identifies damnacanthal as an inhibitor of HIV-1Vpr induced cell death. Biochemical and Biophysical Research Communications, 348(3), 1101-1106.
46. West, B. J., Deng, S., Palu, A. K., & Jensen, C. J. (2009). Morinda citrifolia Linn.(Rubiaceae) leaf extracts mitigate UVB-induced erythema. Journal of natural medicines, 63, 351-354.
47. Luu, T. T. H., Le, T. L., Huynh, N., & Quintela-Alonso, P. (2021). Dragon fruit: A review of health benefits and nutrients and its sustainable development under climate changes in Vietnam. Czech Journal of Food Sciences, 39(2), 71-94.
48. Hossain, F. M., Numan, S. M. N., & Akhtar, S. (2021). Cultivation, nutritional value, and health benefits of Dragon Fruit (Hylocereus spp.): A Review. International Journal of Horticultural Science and Technology, 8(3), 259-269.
49. Nerd, A., Gutman, F., & Mizrahi, Y. (1999). Ripening and postharvest behaviour of fruits of two Hylocereus species (Cactaceae). Postharvest Biology and Technology, 17(1), 39-45.
50. Nobel, P. S., & De la Barrera, E. (2002). Stem water relations and net CO2 uptake for a hemiepiphytic cactus during short-term drought. Environmental and Experimental Botany, 48(2), 129-137.
51. Perween, T., Mandal, K. K., & Hasan, M. A. (2018). Dragon fruit: An exotic super future fruit of India. Journal of Pharmacognosy and Phytochemistry, 7(2), 1022-1026.
52. Joshi, M., & Prabhakar, B. (2020). Phytoconstituents and pharmaco‐therapeutic benefits of pitaya: A wonder fruit. Journal of Food Biochemistry, 44(7), e13260.
53. Lim, H. K., Tan, C. P., Karim, R., Ariffin, A. A., & Bakar, J. (2010). Chemical composition and DSC thermal properties of two species of Hylocereus cacti seed oil: Hylocereus undatus and Hylocereus polyrhizus. Food Chemistry, 119(4), 1326-1331.12.
54. Wong, Y. M., & Siow, L. F. (2015). Effects of heat, pH, antioxidant, agitation and light on betacyanin stability using red-fleshed dragon fruit (Hylocereus polyrhizus) juice and concentrate as models. Journal of food science and technology, 52, 3086-3092.
55. Yi, Y., Wu, X., Wang, Y., Ye, W. C., & Zhang, Q. W. (2011). Studies on the flavonoids from the flowers of Hylocereus undatus. Zhong Yao Cai= Zhongyaocai= Journal of Chinese Medicinal Materials, 34(5), 712-716.
56. Arivalagan, M., Karunakaran, G., Roy, T. K., Dinsha, M., Sindhu, B. C., Shilpashree, V. M., ... & Shivashankara, K. S. (2021). Biochemical and nutritional characterization of dragon fruit (Hylocereus species). Food Chemistry, 353, 129426.
57. Le, N. L. (2022). Functional compounds in dragon fruit peels and their potential health benefits: a review. International Journal of Food Science & Technology, 57(5), 2571-2580.
58. Lodi, K. Z., Cappelari, M. B., Pilatti, G. C., Fontana, R. C., Camassola, M., Salvador, M., & Branco, C. S. (2023). Pre-clinical evidence for the therapeutic effect of Pitaya (Hylocereus lemairei) on diabetic intestinal microenvironment. Natural Product Research, 37(10), 1735-1741.
59. Nishikito, D. F., Borges, A. C. A., Laurindo, L. F., Otoboni, A. M. B., Direito, R., Goulart, R. D. A., ... & Barbalho, S. M. (2023). Anti-inflammatory, antioxidant, and other health effects of dragon fruit and potential delivery systems for its bioactive compounds. Pharmaceutics, 15(1), 159
60. Ibrahim, S. R. M., Mohamed, G. A., Khedr, A. I. M., Zayed, M. F., & El‐Kholy, A. A. E. S. (2018). Genus Hylocereus: Beneficial phytochemicals, nutritional importance, and biological relevance—A review. Journal of Food Biochemistry, 42(2), e12491.
61. Singh, A., Swami, S., Panwar, N. R., Kumar, M., Shukla, A. K., Rouphael, Y., ... & Kumar, P. (2022). Development changes in the physicochemical composition and mineral profile of red-fleshed dragon fruit grown under semi-arid conditions. Agronomy, 12(2), 355.
62. Hossain, F. M., Numan, S. M. N., & Akhtar, S. (2021). Cultivation, nutritional value, and health benefits of Dragon Fruit (Hylocereus spp.): A Review. International Journal of Horticultural Science and Technology, 8(3), 259-269.
63. Ganisetti Anitha, M Viswanath, Pushpa Latha G. (2023). Dragon fruit: A review of health benefits and nutritional importance. Pharma Innovation ,12(1),326-331.
64. Sofowora, A., Ogunbodede, E., & Onayade, A. (2013). The role and place of medicinal plants in the strategies for disease prevention. African journal of traditional, complementary and alternative medicines, 10(5), 210-229.
65. Jeronimo, M. C., Orsine, J. V. C., & Novaes, M. R. C. G. (2017). Nutritional pharmacological and toxicological characteristics of pitaya (Hylocereus undatus): A review of the literature. African Journal of Pharmacy and Pharmacology, 11(27), 300-304.
66. Huang, Y., Brennan, M. A., Kasapis, S., Richardson, S. J., & Brennan, C. S. (2021). Maturation process, nutritional profile, bioactivities and utilisation in food products of red pitaya fruits: A Review. Foods, 10(11), 2862.
67. Nishikito, D. F., Borges, A. C. A., Laurindo, L. F., Otoboni, A. M. B., Direito, R., Goulart, R. D. A., ... & Barbalho, S. M. (2023). Anti-inflammatory, antioxidant, and other health effects of dragon fruit and potential delivery systems for its bioactive compounds. Pharmaceutics, 15(1), 159.
68. Safira, A., Savitri, S. L., Putri, A. R. B., Hamonangan, J. M., Safinda, B., Solikhah, T. I., ... & Puspitarani, G. A. (2021). Review on the pharmacological and health aspects of Hylocereus or Pitaya: An update. Journal of Drug Delivery and Therapeutics, 11(6), 297-303
69. Kumar, S., Tripathi, V., Kumari, A., Chaudhary, V., & Kumawat, P. (2022). A-review: on Nutritional and Medicinal Importance of Dragon Fruit (Hylocereus species). Ecol Environ Conserv, 28, 247-253.
70. Hernández, Y. D. O., & Salazar, J. A. C. (2012). Pitahaya (Hylocereus spp.): a short review. Comunicata Scientiae, 3(4), 220-237.
71. Nurliyana R.D., Syed Zahir I., Mustapha Suleiman K., Aisyah M.R., Kamarul Rahim K. (2010): Antioxidant study of pulps and peels of dragon fruits: A comparative study. International Food Research Journal, 17: 367–375.
72. Rice-Evans, C., Miller, N., & Paganga, G. (1997). Antioxidant properties of phenolic compounds. Trends in plant science, 2(4), 152-159.
73. Saenjum, C.; Pattananandecha, T.; Nakagawa, K. Antioxidative and anti-inflammatory phytochemicals and related stable paramagnetic species in different parts of dragon fruit. Molecules 2021, 26, 3565.
74. Luu, T. T. H., Le, T. L., Huynh, N., & Quintela-Alonso, P. (2021). Dragon fruit: A review of health benefits and nutrients and its sustainable development under climate changes in Vietnam. Czech Journal of Food Sciences, 39(2), 71-94.
75. Rodriguez, E. B., Vidallon, M. L. P., Mendoza, D. J. R., & Reyes, C. T. (2016). Health‐promoting bioactivities of betalains from red dragon fruit (Hylocereus polyrhizus (Weber) Britton and Rose) peels as affected by carbohydrate encapsulation. Journal of the Science of Food and Agriculture, 96(14), 4679-4689.
76. Joshi, M., & Prabhakar, B. (2020). Phytoconstituents and pharmaco‐therapeutic benefits of pitaya: A wonder fruit. Journal of Food Biochemistry, 44(7), e13260.
77. Ibrahim, S. R. M., Mohamed, G. A., Khedr, A. I. M., Zayed, M. F., & El‐Kholy, A. A. E. S. (2018). Genus Hylocereus: Beneficial phytochemicals, nutritional importance, and biological relevance—A review. Journal of Food Biochemistry, 42(2), e12491.
78. Paśko, P., Galanty, A., Zagrodzki, P., Luksirikul, P., Barasch, D., Nemirovski, A., & Gorinstein, S. (2021). Dragon fruits as a reservoir of natural polyphenolics with chemopreventive properties. Molecules, 26(8), 2158.
79. Sudha, K., Baskaran, D., Ramasamy, D., & Siddharth, M. (2017). Evaluation of functional properties of Hylocereus undatus (White dragon fruit). International Journal of Agricultural Science and Research, 7(5), 451-456.
80. De Mello, F. R., Bernardo, C., Dias, C. O., Züge, L. C. B., Silveira, J. L. M., Amante, E. R., & Candido, L. M. B. (2014). Evaluation of the chemical characteristics and rheological behavior of pitaya (Hylocereus undatus) peel. Fruits, 69(5), 381-390.
81. Sushmitha, H. S., Roy, C. L., Gogoi, D., Velagala, R. D., Nagarathna, A., Balasubramanian, S., & Rajadurai, M. (2018). Phytochemical and pharmacological studies on hylocereus undatus seeds: an in vitro approach. World Journal of Pharmacological Research, 7(14), 986-1006.
82. Wichienchot, S., Jatupornpipat, M., & Rastall, R. A. (2010). Oligosaccharides of pitaya (dragon fruit) flesh and their prebiotic properties. Food chemistry, 120(3), 850-857.
83. Nurmahani, M. M., Osman, A., Hamid, A. A., Ghazali, F. M., & Dek, M. S. (2012). Antibacterial property of Hylocereus polyrhizus and Hylocereus undatus peel extracts. International Food research journal, 19(1),77-84.
84. Adhi, N. G. M. A. D., Suastuti, N. W. B., & Putra, A. A. B. (2018). Activity of Hylocereus Costarioensis’s Extract as Antiobesity and hypolipidemic of obese Rats. Int. J. Pharm. Res. Allied Sci, 7(1), 201-208.
85. Widyaningsih, A., Setiyani, O., Umaroh, U., Sofro, M. A. U., & Amri, F. (2017). Effect of consuming red dragon fruit (Hylocereus costaricensis) juice on the levels of hemoglobin and erythrocyte among pregnant women. Belitung Nursing Journal, 3(3), 255-264.
86. Tahir, T., Febrianti, N., Wahyuni, S., & Syam, Y. (2020). Evaluation of acute wound healing potential of red dragon fruit (Hylocereus Polyrhizus) extract cream on type III collagen and epidermal growth factor (EGF) levels: An animal study. Medicina Clínica Práctica, 3, 100091.
87. Krishnaiah, D., Nithyanandam, R., & Sarbatly, R. (2012). Phytochemical constituents and activities of Morinda citrifolia L. Phytochemicals-a global perspective of their role in nutrition and health, 127-150.
88. Zhang, J. H., Xin, H. L., Xu, Y. M., Shen, Y., He, Y. Q., Lin, B., ... & Du, J. (2018). Morinda officinalis How–A comprehensive review of traditional uses, phytochemistry and pharmacology. Journal of Ethnopharmacology, 213, 230-255.
89. Silalahi, M. (2020). Morinda citrifolia: Bioactivity and utilization as traditional medicine and food for the community. International Journal of Business, Economics, and Social Development, 1(2), 81-89.
2. Nagalingam, S., Sasikumar, C. S., & Cherian, K. M. (2013). International Journal of Universal Pharmacy and Bio Sciences,2(6) ,(ISSN): 2319-8141
3. Dixon, A.R., McMillen, H., Etkin, N.L., 1999. Ferment this: the transformation of Noni, a traditional Polynesian medicine (Morinda citrifolia, Rubiaceae). Economic Botany ,53, 51–68.
4. McClatchey, W. (2002). From Polynesian healers to health food stores: changing perspectives of Morinda citrifolia (Rubiaceae). Integrative cancer therapies, 1(2), 110-120.
5. Jadhav, S. B., & Jadhav, N. Y. (2023). An eye catching and comprehensive review on dragon fruit (An exotic super fruit). Journal of Pharmacognosy and Phytochemistry, 12(6), 243-251.
6. Luu, T. T. H., Le, T. L., Huynh, N., & Quintela-Alonso, P. (2021). Dragon fruit: A review of health benefits and nutrients and its sustainable development under climate changes in Vietnam. Czech Journal of Food Sciences, 39(2), 71-94.
7. Vuanghao, L., & Laghari, M. H. (2017). Morinda citrifolia (Noni): A comprehensive review on its industrial uses, pharmacological activities, and clinical trials. Arabian Journal of Chemistry, 10, 691-707
8. Pawlus, A. D., & Kinghorn, A. D. (2007). Review of the ethnobotany, chemistry, biological activity and safety of the botanical dietary supplement Morinda citrifolia (noni). Journal of Pharmacy and pharmacology, 59(12), 1587-1609.
9. Mathivanan, N., Surendiran, G., Srinivasan, K., Sagadevan, E., & Malarvizhi, K. (2005). Review on the current scenario of Noni research: Taxonomy, distribution, chemistry, medicinal and therapeutic values of Morinda citrifolia. International Journal of Noni Research, 1(1), 1-16.
10. Inada, A. C., Figueiredo, P. S., Santos-Eichler, R. A. D., Freitas, K. D. C., Hiane, P. A., Castro, A. P. D., & Guimarães, R. D. C. A. (2017). Morinda citrifolia Linn.(Noni) and its potential in obesity-related metabolic dysfunction. Nutrients, 9(6), 540.
11. Ali, M., Kenganora, M., & Manjula, S. N. (2016). Health benefits of Morinda citrifolia (Noni): A review. Pharmacognosy Journal, 8(4).
12. Morton, J.F., 1992. The ocean-going Noni, or Indian mulberry (Morinda citrifolia, Rubiaceae) and some of its ‘‘colourful’’ relatives. Economic Botony ,46(3), 241–256
13. Elkins, R., 1998. Hawaiian Noni (Morinda citrifolia) Prize Herb of Hawaii and the South Pacific. Woodland Publishing, Utah.
14. Dixon, A. R., McMillen, H., & Etkin, N. L. (1999). Ferment this: the transformation of Noni, a traditional Polynesian medicine (Morinda citrifolia, Rubiaceae). Economic botany, 51-68.
15. Ross, I. A. (2001). Glycyrrhiza glabra. In Medicinal Plants of the World: Chemical Constituents, Traditional and Modern Medicinal Uses, Volume 2 (pp. 191-240). Totowa, NJ: Humana Press.
16. Cardon, D., 2003. Le Monde des Teintures Naturelles. Belin, Paris.
17. Chan-Blanco, Y., Vaillant, F., Perez, A. M., Reynes, M., Brillouet, J. M., & Brat, P. (2006). The noni fruit (Morinda citrifolia L.): A review of agricultural research, nutritional and therapeutic properties. Journal of food composition and analysis, 19(6-7), 645-654.
18. Krishnaiah, D., Nithyanandam, R., & Sarbatly, R. (2012). Phytochemical constituents and activities of Morinda citrifolia L. Phytochemicals-a global perspective of their role in nutrition and health, 127-150.
19. WANG, M. Y., & Su, C. (2001). Cancer preventive effect of Morinda citrifolia (Noni). Annals of the New York Academy of Sciences, 952(1), 161-168.
20. Dittmar, A. (1993). Morinda citrifolia L.-: Use in Indigenous Samoan Medicine. Journal of Herbs, Spices & Medicinal Plants, 1(3), 77–92.
21. Heinicke, R. M. (1985). The pharmacologically active ingredient of Noni. Bulletin of the national tropical Botanical garden, 15(1), 45-52
22. Mahanthesh, M. C., Manjappa, A. S., Shindhe, M. V., Jamkhandi, C. M., Jalapure, S. S., & Patil, S. S. (2013). Morinda citrifolia Linn; A medicinal plant with diverse phytochemicals and its medicinal relevance. World J. Pharm. Res, 3(1), 215-232.
23. Patil, P., Madkaikar, H., & Shah, N. (2022). Morinda citrifolia L.(Noni)-Its ethnobotanical knowledge, phytochemical studies, pharmacological aspects, and future prospects. Int. J. Nov. Res. Dev.(IJNRD), 7, 331-352.
24. Brown, A. C. (2012). Anticancer activity of Morinda citrifolia (Noni) fruit: a review. Phytotherapy Research, 26(10), 1427-1440
25. Chanthira Kumar, H., Lim, X. Y., Mohkiar, F. H., Suhaimi, S. N., Mohammad Shafie, N., & Chin Tan, T. Y. (2022). Efficacy and safety of Morinda citrifolia L.(noni) as a potential anticancer agent. Integrative cancer therapies, 21, 15347354221132848
26. Atkinson, N. (1956). Antibacterial substances from flowering plants. 3. Antibacterial activity of dried Australian Plants by rapid direct plate test, Australian Journal of Experimental Biology, Vol.34(1), pp. 17-26, ISSN 0004-945X
27. Locher, C. P., Burch, M. T., Mower, H. F., Berestecky, J., Davis, H., Van Poel, B., ... & Vlietinck, A. J. (1995). Anti-microbial activity and anti-complement activity of extracts obtained from selected Hawaiian medicinal plants. Journal of ethnopharmacology, 49(1), 23-32.
28. Saludes, J. P., Garson, M. J., Franzblau, S. G., & Aguinaldo, A. M. (2002). Antitubercular constituents from the hexane fraction of Morinda citrifolia Linn.(Rubiaceae). Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives, 16(7), 683-685.
29. Ancolio, C., Azas, N., Mahiou, V., Ollivier, E., Keita, A., Timon David, P., (2000 Feb 29). Anonymous Guinea pig antigenicity study. TAHITIAN NONI® . Product safety labs (Eurofins scientific, Inc) East Drunswick, New Jersey, USA
30. Hirazumi, A., Furusawa, E., Chou, S. C., & Hokama, Y. (1996, January). Immunomodulation contributes to the anticancer activity of morinda citrifolia (noni) fruit juice. In Proceedings of the Western Pharmacology Society (Vol. 39, pp. 7-9).
31. Hirazumi, A., Furusawa, E., Chou, S. C., & Hokama, Y. (1994, January). Anticancer activity of Morinda citrifolia (noni) on intraperitoneally implanted Lewis lung carcinoma in syngeneic mice. In Proceedings of the Western pharmacology society (Vol. 37, pp. 145-146).
32. Anekpankul, T., Goto, M., Sasaki, M., Pavasant, P., & Shotipruk, A. (2007). Extraction of anti-cancer damnacanthal from roots of Morinda citrifolia by subcritical water. Separation and Purification Technology, 55(3), 343-349.
33. Ali, M., Singh, P., Singh, L., Kumar, S., & Scholar, P. G. (2020). Phytochemical Constituents and Pharmacological Activities, Profile of Morinda Citrifolia: A Review. World Journal of Pharmaceutical Research, 9(14), 422.
34. Auerbach, B. J., Kiely, J. S., & Cornicelli, J. A. (1992). A spectrophotometric microtiter-based assay for the detection of hydroperoxy derivatives of linoleic acid. Analytical biochemistry, 201(2), 375-380.
35. Wang, M.Y., Su, C., Nowicki, D., Jensen, J. and Anderson, G. (2001). Morinda citrifolia and cancer prevention. J. Nutrition,131 (11S),3151S
36. Masuda, M., Murata, K., Fukuhama, A., Naruto, S., Fujita, T., Uwaya, A., ... & Matsuda, H. (2009). Inhibitory effects of constituents of Morinda citrifolia seeds on elastase and tyrosinase. Journal of Natural Medicines, 63, 267-273.
37. Jayaraman, S. K., Manoharan, M. S., & Illanchezian, S. (2008). Antibacterial, antifungal and tumor cell suppression potential of Morinda citrifolia fruit extracts. International Journal of Integrative Biology, 3(1), 44-49.
38. Dussossoy, E., Brat, P., Bony, E., Boudard, F., Poucheret, P., Mertz, C., Giaimis, J., & Michel, A. (2011). Characterization, anti-oxidative and anti-inflammatory effects of Costa Rican noni juice (Morinda citrifolia L.). Journal of ethnopharmacology, 133(1), 108–115.
39. Serafini, M. R., Santos, R. C., Guimarães, A. G., Dos Santos, J. P., da Conceicão Santos, A. D., Alves, I. A., Gelain, D. P., de Lima Nogueira, P. C., Quintans-Júnior, L. J., Bonjardim, L. R., & de Souza Araújo, A. A. (2011). Morinda citrifolia Linn leaf extract possesses antioxidant activities and reduces nociceptive behavior and leukocyte migration. Journal of medicinal food, 14(10), 1159–1166.
40. Nerurkar, P. V., Nishioka, A., Eck, P. O., Johns, L. M., Volper, E., & Nerurkar, V. R. (2012). Regulation of glucose metabolism via hepatic forkhead transcription factor 1 (FoxO1) by Morinda citrifolia (noni) in high-fat diet-induced obese mice. British Journal of Nutrition, 108(2), 218-228.
41. Nayak, B. S., Marshall, J. R., Isitor, G., & Adogwa, A. (2011). Hypoglycemic and hepatoprotective activity of fermented fruit juice of Morinda citrifolia (Noni) in diabetic rats. Evidence‐Based Complementary and Alternative Medicine, 2011(1), 875293.
42. Palu, A. K., Kim, A. H., West, B. J., Deng, S., Jensen, J., & White, L. (2008). The effects of Morinda citrifolia L.(noni) on the immune system: its molecular mechanisms of action. Journal of Ethnopharmacology, 115(3), 502-506.
43. Saraswathi, C. D., Prakash, W. S., & Kunal, P. W. (2012). Anti-arthritic activity of Morinda citrifolia L. fruit juice in Complete Freund's Adjuvant induced arthritic rats.
44. Rasal, V. P., Sinnathambi, A., Ashok, P., & Yeshmaina, S. (2008). Wound healing and antioxidant activities of Morinda citrifolia leaf extract in rats.
45. Kamata, M., Wu, R. P., An, D. S., Saxe, J. P., Damoiseaux, R., Phelps, M. E., ... & Chen, I. S. (2006). Cell-based chemical genetic screen identifies damnacanthal as an inhibitor of HIV-1Vpr induced cell death. Biochemical and Biophysical Research Communications, 348(3), 1101-1106.
46. West, B. J., Deng, S., Palu, A. K., & Jensen, C. J. (2009). Morinda citrifolia Linn.(Rubiaceae) leaf extracts mitigate UVB-induced erythema. Journal of natural medicines, 63, 351-354.
47. Luu, T. T. H., Le, T. L., Huynh, N., & Quintela-Alonso, P. (2021). Dragon fruit: A review of health benefits and nutrients and its sustainable development under climate changes in Vietnam. Czech Journal of Food Sciences, 39(2), 71-94.
48. Hossain, F. M., Numan, S. M. N., & Akhtar, S. (2021). Cultivation, nutritional value, and health benefits of Dragon Fruit (Hylocereus spp.): A Review. International Journal of Horticultural Science and Technology, 8(3), 259-269.
49. Nerd, A., Gutman, F., & Mizrahi, Y. (1999). Ripening and postharvest behaviour of fruits of two Hylocereus species (Cactaceae). Postharvest Biology and Technology, 17(1), 39-45.
50. Nobel, P. S., & De la Barrera, E. (2002). Stem water relations and net CO2 uptake for a hemiepiphytic cactus during short-term drought. Environmental and Experimental Botany, 48(2), 129-137.
51. Perween, T., Mandal, K. K., & Hasan, M. A. (2018). Dragon fruit: An exotic super future fruit of India. Journal of Pharmacognosy and Phytochemistry, 7(2), 1022-1026.
52. Joshi, M., & Prabhakar, B. (2020). Phytoconstituents and pharmaco‐therapeutic benefits of pitaya: A wonder fruit. Journal of Food Biochemistry, 44(7), e13260.
53. Lim, H. K., Tan, C. P., Karim, R., Ariffin, A. A., & Bakar, J. (2010). Chemical composition and DSC thermal properties of two species of Hylocereus cacti seed oil: Hylocereus undatus and Hylocereus polyrhizus. Food Chemistry, 119(4), 1326-1331.12.
54. Wong, Y. M., & Siow, L. F. (2015). Effects of heat, pH, antioxidant, agitation and light on betacyanin stability using red-fleshed dragon fruit (Hylocereus polyrhizus) juice and concentrate as models. Journal of food science and technology, 52, 3086-3092.
55. Yi, Y., Wu, X., Wang, Y., Ye, W. C., & Zhang, Q. W. (2011). Studies on the flavonoids from the flowers of Hylocereus undatus. Zhong Yao Cai= Zhongyaocai= Journal of Chinese Medicinal Materials, 34(5), 712-716.
56. Arivalagan, M., Karunakaran, G., Roy, T. K., Dinsha, M., Sindhu, B. C., Shilpashree, V. M., ... & Shivashankara, K. S. (2021). Biochemical and nutritional characterization of dragon fruit (Hylocereus species). Food Chemistry, 353, 129426.
57. Le, N. L. (2022). Functional compounds in dragon fruit peels and their potential health benefits: a review. International Journal of Food Science & Technology, 57(5), 2571-2580.
58. Lodi, K. Z., Cappelari, M. B., Pilatti, G. C., Fontana, R. C., Camassola, M., Salvador, M., & Branco, C. S. (2023). Pre-clinical evidence for the therapeutic effect of Pitaya (Hylocereus lemairei) on diabetic intestinal microenvironment. Natural Product Research, 37(10), 1735-1741.
59. Nishikito, D. F., Borges, A. C. A., Laurindo, L. F., Otoboni, A. M. B., Direito, R., Goulart, R. D. A., ... & Barbalho, S. M. (2023). Anti-inflammatory, antioxidant, and other health effects of dragon fruit and potential delivery systems for its bioactive compounds. Pharmaceutics, 15(1), 159
60. Ibrahim, S. R. M., Mohamed, G. A., Khedr, A. I. M., Zayed, M. F., & El‐Kholy, A. A. E. S. (2018). Genus Hylocereus: Beneficial phytochemicals, nutritional importance, and biological relevance—A review. Journal of Food Biochemistry, 42(2), e12491.
61. Singh, A., Swami, S., Panwar, N. R., Kumar, M., Shukla, A. K., Rouphael, Y., ... & Kumar, P. (2022). Development changes in the physicochemical composition and mineral profile of red-fleshed dragon fruit grown under semi-arid conditions. Agronomy, 12(2), 355.
62. Hossain, F. M., Numan, S. M. N., & Akhtar, S. (2021). Cultivation, nutritional value, and health benefits of Dragon Fruit (Hylocereus spp.): A Review. International Journal of Horticultural Science and Technology, 8(3), 259-269.
63. Ganisetti Anitha, M Viswanath, Pushpa Latha G. (2023). Dragon fruit: A review of health benefits and nutritional importance. Pharma Innovation ,12(1),326-331.
64. Sofowora, A., Ogunbodede, E., & Onayade, A. (2013). The role and place of medicinal plants in the strategies for disease prevention. African journal of traditional, complementary and alternative medicines, 10(5), 210-229.
65. Jeronimo, M. C., Orsine, J. V. C., & Novaes, M. R. C. G. (2017). Nutritional pharmacological and toxicological characteristics of pitaya (Hylocereus undatus): A review of the literature. African Journal of Pharmacy and Pharmacology, 11(27), 300-304.
66. Huang, Y., Brennan, M. A., Kasapis, S., Richardson, S. J., & Brennan, C. S. (2021). Maturation process, nutritional profile, bioactivities and utilisation in food products of red pitaya fruits: A Review. Foods, 10(11), 2862.
67. Nishikito, D. F., Borges, A. C. A., Laurindo, L. F., Otoboni, A. M. B., Direito, R., Goulart, R. D. A., ... & Barbalho, S. M. (2023). Anti-inflammatory, antioxidant, and other health effects of dragon fruit and potential delivery systems for its bioactive compounds. Pharmaceutics, 15(1), 159.
68. Safira, A., Savitri, S. L., Putri, A. R. B., Hamonangan, J. M., Safinda, B., Solikhah, T. I., ... & Puspitarani, G. A. (2021). Review on the pharmacological and health aspects of Hylocereus or Pitaya: An update. Journal of Drug Delivery and Therapeutics, 11(6), 297-303
69. Kumar, S., Tripathi, V., Kumari, A., Chaudhary, V., & Kumawat, P. (2022). A-review: on Nutritional and Medicinal Importance of Dragon Fruit (Hylocereus species). Ecol Environ Conserv, 28, 247-253.
70. Hernández, Y. D. O., & Salazar, J. A. C. (2012). Pitahaya (Hylocereus spp.): a short review. Comunicata Scientiae, 3(4), 220-237.
71. Nurliyana R.D., Syed Zahir I., Mustapha Suleiman K., Aisyah M.R., Kamarul Rahim K. (2010): Antioxidant study of pulps and peels of dragon fruits: A comparative study. International Food Research Journal, 17: 367–375.
72. Rice-Evans, C., Miller, N., & Paganga, G. (1997). Antioxidant properties of phenolic compounds. Trends in plant science, 2(4), 152-159.
73. Saenjum, C.; Pattananandecha, T.; Nakagawa, K. Antioxidative and anti-inflammatory phytochemicals and related stable paramagnetic species in different parts of dragon fruit. Molecules 2021, 26, 3565.
74. Luu, T. T. H., Le, T. L., Huynh, N., & Quintela-Alonso, P. (2021). Dragon fruit: A review of health benefits and nutrients and its sustainable development under climate changes in Vietnam. Czech Journal of Food Sciences, 39(2), 71-94.
75. Rodriguez, E. B., Vidallon, M. L. P., Mendoza, D. J. R., & Reyes, C. T. (2016). Health‐promoting bioactivities of betalains from red dragon fruit (Hylocereus polyrhizus (Weber) Britton and Rose) peels as affected by carbohydrate encapsulation. Journal of the Science of Food and Agriculture, 96(14), 4679-4689.
76. Joshi, M., & Prabhakar, B. (2020). Phytoconstituents and pharmaco‐therapeutic benefits of pitaya: A wonder fruit. Journal of Food Biochemistry, 44(7), e13260.
77. Ibrahim, S. R. M., Mohamed, G. A., Khedr, A. I. M., Zayed, M. F., & El‐Kholy, A. A. E. S. (2018). Genus Hylocereus: Beneficial phytochemicals, nutritional importance, and biological relevance—A review. Journal of Food Biochemistry, 42(2), e12491.
78. Paśko, P., Galanty, A., Zagrodzki, P., Luksirikul, P., Barasch, D., Nemirovski, A., & Gorinstein, S. (2021). Dragon fruits as a reservoir of natural polyphenolics with chemopreventive properties. Molecules, 26(8), 2158.
79. Sudha, K., Baskaran, D., Ramasamy, D., & Siddharth, M. (2017). Evaluation of functional properties of Hylocereus undatus (White dragon fruit). International Journal of Agricultural Science and Research, 7(5), 451-456.
80. De Mello, F. R., Bernardo, C., Dias, C. O., Züge, L. C. B., Silveira, J. L. M., Amante, E. R., & Candido, L. M. B. (2014). Evaluation of the chemical characteristics and rheological behavior of pitaya (Hylocereus undatus) peel. Fruits, 69(5), 381-390.
81. Sushmitha, H. S., Roy, C. L., Gogoi, D., Velagala, R. D., Nagarathna, A., Balasubramanian, S., & Rajadurai, M. (2018). Phytochemical and pharmacological studies on hylocereus undatus seeds: an in vitro approach. World Journal of Pharmacological Research, 7(14), 986-1006.
82. Wichienchot, S., Jatupornpipat, M., & Rastall, R. A. (2010). Oligosaccharides of pitaya (dragon fruit) flesh and their prebiotic properties. Food chemistry, 120(3), 850-857.
83. Nurmahani, M. M., Osman, A., Hamid, A. A., Ghazali, F. M., & Dek, M. S. (2012). Antibacterial property of Hylocereus polyrhizus and Hylocereus undatus peel extracts. International Food research journal, 19(1),77-84.
84. Adhi, N. G. M. A. D., Suastuti, N. W. B., & Putra, A. A. B. (2018). Activity of Hylocereus Costarioensis’s Extract as Antiobesity and hypolipidemic of obese Rats. Int. J. Pharm. Res. Allied Sci, 7(1), 201-208.
85. Widyaningsih, A., Setiyani, O., Umaroh, U., Sofro, M. A. U., & Amri, F. (2017). Effect of consuming red dragon fruit (Hylocereus costaricensis) juice on the levels of hemoglobin and erythrocyte among pregnant women. Belitung Nursing Journal, 3(3), 255-264.
86. Tahir, T., Febrianti, N., Wahyuni, S., & Syam, Y. (2020). Evaluation of acute wound healing potential of red dragon fruit (Hylocereus Polyrhizus) extract cream on type III collagen and epidermal growth factor (EGF) levels: An animal study. Medicina Clínica Práctica, 3, 100091.
87. Krishnaiah, D., Nithyanandam, R., & Sarbatly, R. (2012). Phytochemical constituents and activities of Morinda citrifolia L. Phytochemicals-a global perspective of their role in nutrition and health, 127-150.
88. Zhang, J. H., Xin, H. L., Xu, Y. M., Shen, Y., He, Y. Q., Lin, B., ... & Du, J. (2018). Morinda officinalis How–A comprehensive review of traditional uses, phytochemistry and pharmacology. Journal of Ethnopharmacology, 213, 230-255.
89. Silalahi, M. (2020). Morinda citrifolia: Bioactivity and utilization as traditional medicine and food for the community. International Journal of Business, Economics, and Social Development, 1(2), 81-89.
Article Sidebar
Published
Dec 11, 2024
Article Details
How to Cite
Vishwa Patel, Ms. Foram Mehta, & Dr. Pragnesh Patani. (2024). MORINDA CITRIFOLIA L. AND HYLOCEREUS SPP: FROM TRADITIONAL USES TO MODERN APPLICATIONS. Journal of Population Therapeutics and Clinical Pharmacology, 31(11), 1080-1095. https://doi.org/10.53555/gwk4ex92
Section
Articles
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Author Biographies
Vishwa Patel
Student, Khyati College of Pharmacy, Palodia, Ahmedabad
Ms. Foram Mehta
Assistant Professor, Khyati College of Pharmacy, Palodia, Ahmedabad
Dr. Pragnesh Patani
Principal, Khyati College of Pharmacy, Palodia, Ahmedabad
How to Cite
Vishwa Patel, Ms. Foram Mehta, & Dr. Pragnesh Patani. (2024). MORINDA CITRIFOLIA L. AND HYLOCEREUS SPP: FROM TRADITIONAL USES TO MODERN APPLICATIONS. Journal of Population Therapeutics and Clinical Pharmacology, 31(11), 1080-1095. https://doi.org/10.53555/gwk4ex92